REVB stock news
This page provides real-time market news, earnings updates, and company announcements related to Revelation Biosciences, Inc. (REVB).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-07 04:51 EST
Alibaba's $100 Billion AI Gamble Ignites a 3.4% Surge: The Cloud Revolution Begins
101 finance2026-03-25 19:06:47
US-Iran Tensions Latest: Diplomatic Deadlock Drives Market Fluctuations as Trump Prolongs Suspension of Attacks on Energy Facilities
101 finance2026-03-27 00:52:18
NVIDIA’s $1.7B Concealed Movement: An Examination of the $1B Class Action Flow
101 finance2026-03-27 07:21:52
Entergy Faces Regulatory Crossroads: Can Louisiana Gas Plant Approval Deliver $5B in Savings or Trigger Ratepayer Risk?
101 finance2026-03-27 14:51:36
Vertex's Renal Pipeline Faces Crucial 2026 Data Tests as "Buy the Rumor" Premium Meets Reality
101 finance2026-03-27 16:54:46
Entegris Stands Out as a Strong Choice During Industry Downturn and AI-Fueled Capital Investment Boom
101 finance2026-03-29 09:58:09
Anthropic’s “Mythos” Leak Triggers Cybersecurity Stock Decline: Adjusting for AI Threats or an Excessive Market Response?
101 finance2026-03-30 05:27:43
Bank of America's Epstein Settlement: Legal Exit or Reputational Precedent?
101 finance2026-03-30 08:43:06
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
Finviz2026-03-30 13:09:49
Could Issues at Super Micro Computer Cause Nvidia's Shares to Fall?
101 finance2026-03-30 22:00:57
Global AI’s 15% decline didn’t come as a surprise—it serves as evidence of significant underlying market distress.
101 finance2026-03-31 23:12:44
Insulet's PODD Rises to Top in Trading Volume Amid Defect Controversy and Legal Scrutiny
101 finance2026-04-02 00:15:53
Blue Owl’s Behavioral Sell-Off Overlooked: Crowd Anxiety Misses Competitor Success and Smooth Loan Departure
101 finance2026-04-02 13:18:57
Ultragenyx Legal Deadline Looms—Setrusumab Mispricing Sparks Trade Setup Amid GTX-102 Hope
101 finance2026-04-02 14:34:00
Why the Kraft Heinz Reversal Is Great News for Berkshire Hathaway Investors
101 finance2026-04-02 20:15:50
MINISO's Q4 Revenue Beat Was Already Priced In—Profitability Remains the Wild Card
101 finance2026-04-02 23:04:04
Tarsus's TP-05 Trial Start May Signal Priced-In Optimism Is Already Built In
101 finance2026-04-03 05:33:49
NuScale (SMR) Approaches Legal Cutoff—April 20 Event May Prompt Partnership Decisions
101 finance2026-04-04 01:45:46
DRVN's legal and financial turmoil generates uneven alpha in the competition for lead plaintiff
101 finance2026-04-04 16:51:44
PayPal's April 20 Legal Deadline: Tactical Volatility Play Amid Unchanged Long-Term Fundamentals
101 finance2026-04-05 22:48:38
Enphase Energy: CEO Purchases Shares as CFO Offloads in a Typical Pump-and-Dump Scenario with Legal Action Looming
101 finance2026-04-06 07:18:51
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
Finviz2026-04-06 13:00:53
Revelation Biosciences Approaches Critical Juncture as Gemini Study Finalizes and Funding Timeline Tightens
101 finance2026-04-06 13:33:43
Corcept CEO Offloads $1.3M After FDA Nod While Savvy Investors Raise Concerns Over Legal Uncertainty
101 finance2026-04-06 16:40:11
Vertex's Renal Pipeline Faces Crucial 2026 Data Tests as "Buy the Rumor" Premium Meets Reality
101 finance2026-03-27 16:54:46
Entegris Stands Out as a Strong Choice During Industry Downturn and AI-Fueled Capital Investment Boom
101 finance2026-03-29 09:58:09
Anthropic’s “Mythos” Leak Triggers Cybersecurity Stock Decline: Adjusting for AI Threats or an Excessive Market Response?
101 finance2026-03-30 05:27:43
Bank of America's Epstein Settlement: Legal Exit or Reputational Precedent?
101 finance2026-03-30 08:43:06
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
Finviz2026-03-30 13:09:49
Could Issues at Super Micro Computer Cause Nvidia's Shares to Fall?
101 finance2026-03-30 22:00:57
Global AI’s 15% decline didn’t come as a surprise—it serves as evidence of significant underlying market distress.
101 finance2026-03-31 23:12:44
Insulet's PODD Rises to Top in Trading Volume Amid Defect Controversy and Legal Scrutiny
101 finance2026-04-02 00:15:53
Blue Owl’s Behavioral Sell-Off Overlooked: Crowd Anxiety Misses Competitor Success and Smooth Loan Departure
101 finance2026-04-02 13:18:57
Ultragenyx Legal Deadline Looms—Setrusumab Mispricing Sparks Trade Setup Amid GTX-102 Hope
101 finance2026-04-02 14:34:00
Why the Kraft Heinz Reversal Is Great News for Berkshire Hathaway Investors
101 finance2026-04-02 20:15:50
MINISO's Q4 Revenue Beat Was Already Priced In—Profitability Remains the Wild Card
101 finance2026-04-02 23:04:04
Tarsus's TP-05 Trial Start May Signal Priced-In Optimism Is Already Built In
101 finance2026-04-03 05:33:49
NuScale (SMR) Approaches Legal Cutoff—April 20 Event May Prompt Partnership Decisions
101 finance2026-04-04 01:45:46
DRVN's legal and financial turmoil generates uneven alpha in the competition for lead plaintiff
101 finance2026-04-04 16:51:44
PayPal's April 20 Legal Deadline: Tactical Volatility Play Amid Unchanged Long-Term Fundamentals
101 finance2026-04-05 22:48:38
Enphase Energy: CEO Purchases Shares as CFO Offloads in a Typical Pump-and-Dump Scenario with Legal Action Looming
101 finance2026-04-06 07:18:51
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
Finviz2026-04-06 13:00:53
Revelation Biosciences Approaches Critical Juncture as Gemini Study Finalizes and Funding Timeline Tightens
101 finance2026-04-06 13:33:43
Corcept CEO Offloads $1.3M After FDA Nod While Savvy Investors Raise Concerns Over Legal Uncertainty
101 finance2026-04-06 16:40:11
REVB stock chart
REVB stock detailsREVB stock price change
On the last trading day, REVB stock closed at 1.25 USD, with a price change of 1.63% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more